GlassScriptPhysician profile
Joseph A Samady
NPI 1013954908
$9,664.88
in general payments reported to CMS, 2019-2025
33 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $518 · 2021: $1,492 · 2022: $1,688 · 2023: $1,630 · 2024: $1,993 · 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,703 · Education: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,702.63 |
| Education | $396.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,600.41 | 2019-2025 | Skyrizi, Rinvoq, Botox |
| Janssen Biotech, INC. | $1,462.86 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Genzyme Corporation | $740.09 | 2019-2025 | |
| Lilly USA, LLC | $651.69 | 2020-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $633.54 | 2021-2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $568.86 | 2019-2024 | Ilumya |
| Ucb, INC. | $539.41 | 2020-2025 | Bimzelx, Cimzia, Briviact |
| Regeneron Healthcare Solutions, INC. | $526.97 | 2019-2025 | Libtayo, Dupixent |
| Galderma Laboratories, L.P. | $496.54 | 2019-2025 | Nemluvio |
| Incyte Corporation | $473.41 | 2021-2025 | Opzelura |
| Pfizer INC. | $385.36 | 2019-2025 | |
| Amgen INC. | $323.93 | 2021-2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $310.78 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $188.13 | 2023-2024 | Sotyktu |
| Journey Medical Corporation | $116.86 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $68.19 | 2024-2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $67.02 | 2021 | |
| Strata Skin Sciences, INC. | $61.51 | 2023-2024 | Xtrac |
| Stemline Therapeutics INC. | $57.11 | 2021 | |
| Vyne Pharmaceuticals INC. | $53.00 | 2021 | |
| Celgene Corporation | $45.76 | 2019 | |
| Almirall LLC | $37.12 | 2019-2023 | Klisyri |
| Bioventus LLC | $33.96 | 2022 | |
| Organon LLC | $32.34 | 2025 | Vtama |
| Allergan, INC. | $32.20 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $28.08 | 2022-2023 | Jublia, Bryhali, Arazlo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.46 | 2024 | Spevigo |
| Solta Medical, A Division of Bausch Health US, LLC | $19.80 | 2021 | |
| Botanix Sb INC | $19.66 | 2025 | Sofdra |
| Verrica Pharmaceuticals INC. | $18.63 | 2024 | Ycanth |
| Dermavant Sciences, INC. | $16.63 | 2024 | Vtama |
| Biofrontera INC. | $16.58 | 2021 | |
| Dusa Pharmaceuticals, INC. | $14.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Samady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.